| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.42 | 0.0005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |